Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds SoftBank Moves to Sell Down its Stake in Alibaba

SoftBank Moves to Sell Down its Stake in Alibaba

-FT https://www.ft.com/content/ac5a0a5b-36f0-49b2-a0c1-c08948465245?FTCamp=engage/CAPI/app/Channel_Refinitiv//B2B

byCharles Gross

August 4, 2022

1 minute read

-FT

https://www.ft.com/content/ac5a0a5b-36f0-49b2-a0c1-c08948465245?FTCamp=engage/CAPI/app/Channel_Refinitiv//B2B

Citigroup Maintains Neutral on Pactiv Evergreen, Lowers Price Target to $10

By Benzinga Newsdesk

March 8, 7:19 AM

Citigroup analyst Anthony Pettinari maintains Pactiv Evergreen (NASDAQ:PTVE) with a Neutral and lowers the price target from $12 to $10.

PTVE

HC Wainwright Downgrades Angion Biomedica

By Vandana Singh

July 18, 2:53 PM

Last month, Angion Biomedica Corp (NASDAQ:ANGN) discontinued the JUNIPER Phase 2 dose-finding trial of ANG-3070 in primary proteinuric kidney diseases, specifically focal…

ANGN

Why Aridis Pharmaceuticals Shares Are Soaring Today

By Ryan Gustafson

May 31, 3:51 PM

Aridis Pharmaceuticals Inc. (NASDAQ: ARDS) shares popped over 100% Wednesday afternoon after the company announced it received an agreement from the FDA on a single confirmatory Phase 3 study of AR-301.

ARDS